IDHC Stock Overview
A consumer healthcare company, provides various medical diagnostics services to patients.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 5/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Integrated Diagnostics Holdings plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.35 |
| 52 Week High | US$0.53 |
| 52 Week Low | US$0.28 |
| Beta | 0.59 |
| 11 Month Change | -11.30% |
| 3 Month Change | 8.31% |
| 1 Year Change | -15.73% |
| 33 Year Change | -72.02% |
| 5 Year Change | -69.96% |
| Change since IPO | -75.32% |
Recent News & Updates
Recent updates
Integrated Diagnostics Holdings (LON:IDHC) Will Be Hoping To Turn Its Returns On Capital Around
Nov 07
Is Integrated Diagnostics Holdings (LON:IDHC) A Risky Investment?
Oct 17Returns On Capital Signal Tricky Times Ahead For Integrated Diagnostics Holdings (LON:IDHC)
Jun 22Integrated Diagnostics Holdings' (LON:IDHC) Problems Go Beyond Weak Profit
Nov 25Does Integrated Diagnostics Holdings (LON:IDHC) Have A Healthy Balance Sheet?
Sep 06Shareholder Returns
| IDHC | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | -2.7% | 2.0% | -0.7% |
| 1Y | -15.7% | -11.7% | 6.7% |
Return vs Industry: IDHC underperformed the UK Healthcare industry which returned -11.7% over the past year.
Return vs Market: IDHC underperformed the UK Market which returned 6.7% over the past year.
Price Volatility
| IDHC volatility | |
|---|---|
| IDHC Average Weekly Movement | 8.9% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in GB Market | 9.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: IDHC's share price has been volatile over the past 3 months.
Volatility Over Time: IDHC's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 6,692 | Hend El Sherbini | www.idhcorp.com |
Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, including positron emission tomography – computed tomography (PET-CT), magnetic resonance imaging (MRI), computed tomography (CT), mammography, ultrasound, x-ray, electromyography (EMG), electroencephalography, electroencephalogram (EEG), and electrocardiogram (ECG), as well as operates cath lab facilities.
Integrated Diagnostics Holdings plc Fundamentals Summary
| IDHC fundamental statistics | |
|---|---|
| Market cap | US$200.85m |
| Earnings (TTM) | US$16.80m |
| Revenue (TTM) | US$97.60m |
12.0x
P/E Ratio2.1x
P/S RatioIs IDHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IDHC income statement (TTM) | |
|---|---|
| Revenue | ج.م4.75b |
| Cost of Revenue | ج.م2.96b |
| Gross Profit | ج.م1.79b |
| Other Expenses | ج.م974.03m |
| Earnings | ج.م817.28m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.41 |
| Gross Margin | 37.72% |
| Net Profit Margin | 17.21% |
| Debt/Equity Ratio | 2.6% |
How did IDHC perform over the long term?
See historical performance and comparison